Perivascular nitric oxide gradients normalize tumor vasculature

Nat Med. 2008 Mar;14(3):255-7. doi: 10.1038/nm1730. Epub 2008 Feb 17.

Abstract

Normalization of tumor vasculature is an emerging strategy to improve cytotoxic therapies. Here we show that eliminating nitric oxide (NO) production from tumor cells via neuronal NO synthase silencing or inhibition establishes perivascular gradients of NO in human glioma xenografts in mice and normalizes the tumor vasculature, resulting in improved tumor oxygenation and response to radiation treatment. Creation of perivascular NO gradients may be an effective strategy for normalizing abnormal vasculature.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Gene Silencing
  • Glioma / blood supply*
  • Glioma / metabolism*
  • Glioma / radiotherapy
  • Homeodomain Proteins / genetics
  • Homeodomain Proteins / metabolism
  • Humans
  • Mice
  • Mice, Knockout
  • Neoplasms, Experimental / enzymology
  • Neoplasms, Experimental / metabolism
  • Neoplasms, Experimental / radiotherapy
  • Nitric Oxide / metabolism*
  • Nitric Oxide Synthase Type I / deficiency
  • Nitric Oxide Synthase Type I / genetics
  • Nitric Oxide Synthase Type I / metabolism
  • Nitric Oxide Synthase Type III / deficiency
  • Nitric Oxide Synthase Type III / genetics
  • Nitric Oxide Synthase Type III / metabolism
  • Oxygen / metabolism

Substances

  • Homeodomain Proteins
  • RAG-1 protein
  • Nitric Oxide
  • Nitric Oxide Synthase Type I
  • Nitric Oxide Synthase Type III
  • Oxygen